Completed NA INTERVENTIONAL 3-arm NCT04758728

Adrenaline Reduces Ecchymoses and Hematomas and Improves Quality of Life After Classic Saphenous Vein Stripping (ARESQOLSAVES)

The Role of Adrenaline in the Reduction of Subcutaneous Ecchymoses and Hematomas and in the Improvement of the Quality of Life of Patients After Classic Great Saphenous Vein Stripping

Sponsor: General Hospital of Rhodes Andreas Papandreou

Conditions Bruising Ecchymosis Subcutaneous Haematoma Venous Disease Venous Insufficiency (Chronic)(Peripheral) Venous Insufficiency of Leg Venous Reflux Venous Stasis

Interventions Epinephrine Topical Great saphenous vein stripping and varicectomies normal saline

Updated 4 times since 2021 Last updated: Feb 17, 2021 Started: Sep 10, 2015 Primary completion: May 14, 2016 Completion: Jun 10, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04758728, this NA trial focuses on Bruising and Ecchymosis and remains completed. Sponsored by General Hospital of Rhodes Andreas Papandreou, it has been updated 4 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA
Mar 2021 — Nov 2023 [monthly]

Completed NA

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital of Rhodes Andreas Papandreou
Hellenic Red Cross Hospital
Junior Doctors Network-Hellas

Data source: Junior Doctors Network-Hellas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rhodes, Greece